Pfizer Limited (PFIZER) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.156x

Based on the latest financial reports, Pfizer Limited (PFIZER) has a cash flow conversion efficiency ratio of 0.156x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.99 Billion ≈ $64.83 Million USD) by net assets (Rs38.48 Billion ≈ $416.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Pfizer Limited defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Pfizer Limited - Cash Flow Conversion Efficiency Trend (2005–2026)

This chart illustrates how Pfizer Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Pfizer Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pfizer Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Youngone
KO:111770
0.092x
HeiLongJiang Kingland Technology Co Ltd
SHE:000711
-0.014x
BW LPG Limited
F:BW9
0.094x
Hawaiian Electric Industries Inc
NYSE:HE
0.037x
Südzucker AG
F:SZU
-0.001x
P/F Bakkafrost
F:6BF
0.041x
Iluka Resources Limited
F:ILZ
0.011x
XiAn Shaangu Power Co Ltd
SHG:601369
0.035x

Annual Cash Flow Conversion Efficiency for Pfizer Limited (2005–2026)

The table below shows the annual cash flow conversion efficiency of Pfizer Limited from 2005 to 2026. For the full company profile with market capitalisation and key ratios, see Pfizer Limited market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs42.03 Billion
≈ $454.53 Million
Rs11.44 Billion
≈ $123.67 Million
0.272x +73.94%
2025-03-31 Rs42.17 Billion
≈ $456.10 Million
Rs6.60 Billion
≈ $71.35 Million
0.156x +119.00%
2024-03-31 Rs35.96 Billion
≈ $388.84 Million
Rs2.57 Billion
≈ $27.78 Million
0.071x -35.59%
2023-03-31 Rs32.07 Billion
≈ $346.86 Million
Rs3.56 Billion
≈ $38.47 Million
0.111x -52.38%
2022-03-31 Rs28.64 Billion
≈ $309.78 Million
Rs6.67 Billion
≈ $72.14 Million
0.233x +30.42%
2021-03-31 Rs23.93 Billion
≈ $258.80 Million
Rs4.27 Billion
≈ $46.21 Million
0.179x +87.62%
2020-03-31 Rs33.95 Billion
≈ $367.21 Million
Rs3.23 Billion
≈ $34.95 Million
0.095x +193.03%
2019-03-31 Rs30.11 Billion
≈ $325.66 Million
Rs978.10 Million
≈ $10.58 Million
0.032x -73.73%
2018-03-31 Rs26.83 Billion
≈ $290.18 Million
Rs3.32 Billion
≈ $35.88 Million
0.124x -9.03%
2017-03-31 Rs24.19 Billion
≈ $261.59 Million
Rs3.29 Billion
≈ $35.56 Million
0.136x -16.22%
2016-03-31 Rs21.18 Billion
≈ $229.05 Million
Rs3.44 Billion
≈ $37.16 Million
0.162x +182.10%
2015-03-31 Rs19.73 Billion
≈ $213.37 Million
Rs1.13 Billion
≈ $12.27 Million
0.058x -71.41%
2014-03-31 Rs6.58 Billion
≈ $71.20 Million
Rs1.32 Billion
≈ $14.32 Million
0.201x +4060.27%
2013-03-31 Rs16.94 Billion
≈ $183.25 Million
Rs-86.07 Million
≈ $-930.79K
-0.005x -127.10%
2012-03-31 Rs13.05 Billion
≈ $141.10 Million
Rs244.59 Million
≈ $2.65 Million
0.019x -86.64%
2011-03-31 Rs11.63 Billion
≈ $125.82 Million
Rs1.63 Billion
≈ $17.66 Million
0.140x +86.88%
2010-03-31 Rs9.94 Billion
≈ $107.53 Million
Rs746.73 Million
≈ $8.08 Million
0.075x -71.54%
2009-03-31 Rs9.01 Billion
≈ $97.45 Million
Rs2.38 Billion
≈ $25.71 Million
0.264x +941.98%
2008-03-31 Rs6.50 Billion
≈ $70.26 Million
Rs164.53 Million
≈ $1.78 Million
0.025x -90.96%
2007-03-31 Rs4.40 Billion
≈ $47.56 Million
Rs1.23 Billion
≈ $13.32 Million
0.280x +2.51%
2006-03-31 Rs3.76 Billion
≈ $40.66 Million
Rs1.03 Billion
≈ $11.11 Million
0.273x +6.40%
2005-03-31 Rs3.40 Billion
≈ $36.72 Million
Rs872.08 Million
≈ $9.43 Million
0.257x --

About Pfizer Limited

NSE:PFIZER India Drug Manufacturers - General
Market Cap
$2.25 Billion
Rs207.66 Billion INR
Market Cap Rank
#5933 Global
#261 in India
Share Price
Rs4539.30
Change (1 day)
+1.02%
52-Week Range
Rs4422.40 - Rs5851.00
All Time High
Rs6318.30
About

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vi… Read more